Drug No Better Than Placebo To Treat Behavioural Symptoms Of Alzheimer’s, UK

New research has found that donepezil (known commercially as Aricept©) is no more effective than a placebo at tackling the agitation which often accompanies Alzheimer’s disease. The findings, published in the New England Journal of Medicine, result from the CALM-AD trial which was set up by the Medical Research Council to look into the potential use of donepezil, to address the behavioural symptoms associated with Alzheimer’s disease. [click link for full article]

More: continued here

Filed under: Alzheimer's / Dementia News XML/RSS Feed on October 5th, 2007